Recombinant Mononegaviral Virus Vectors with Non-Coding Regions

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current recombinant Mononegavirales virus vectors do not achieve optimal expression levels of foreign genes and immunogenicity, as they lack the beneficial effects of non-coding regions in gene transcription units.

Innovation Solution

Incorporating 3′ and 5′ non-coding regions of Mononegavirales virus genes flanking the foreign gene within the recombinant vector, specifically between the gene start and stop codons, to enhance transcription and protein expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If foreign genes are inserted into Mononegavirales virus vectors without non-coding regions, then the vector structure remains simple, but the expression level of foreign genes is insufficient

Engineering Contradiction:
Improveexpression level of foreign geneVSAvoidvector structure complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The non-coding regions are pre-positioned flanking the foreign gene within the transcription unit, prepared in advance to facilitate high-level expression. This preliminary arrangement of regulatory elements ensures that when the virus infects host cells, the foreign gene is immediately subjected to optimal transcriptional control, resolving the contradiction by having the structural complexity ready beforehand rather than requiring complex regulatory mechanisms to develop during expression.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The non-coding regions act as intermediary elements between the viral transcription machinery and the foreign gene. These regions, containing promoter elements and other regulatory sequences, mediate the interaction between the viral RNA polymerase and the foreign gene, enabling efficient transcription without requiring direct integration of complex eukaryotic regulatory elements, thus resolving the contradiction by using viral-derived intermediaries.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If foreign genes are inserted into Mononegavirales virus vectors, then the vaccine can elicit immune response, but the immunogenicity is not optimal without non-coding regions

Engineering Contradiction:
ImproveimmunogenicityVSAvoidtranscription unit structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention changes the transcriptional parameters of the foreign gene by flanking it with non-coding regions containing specific promoter elements and regulatory sequences. This parameter change in the transcriptional environment transforms the foreign gene from a poorly expressed insert to a highly expressed antigen, thereby improving immunogenicity. The non-coding regions modify key transcriptional parameters such as initiation efficiency and mRNA stability without requiring complex post-translational modifications or additional viral components.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If non-coding regions are added to flank the foreign gene, then mRNA synthesis and protein expression increase, but the transcription unit becomes more complex

Engineering Contradiction:
ImprovemRNA synthesis rateVSAvoidtranscription unit composition
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The non-coding regions serve multiple functions simultaneously: they provide promoter activity for transcription initiation, contain regulatory elements for mRNA processing and stability, and facilitate efficient coupling between transcription and translation. This multi-functionality allows a single structural addition (the non-coding regions) to accomplish multiple objectives that would otherwise require separate complex regulatory elements, thereby increasing productivity without proportionally increasing complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS7951587B2Recombinant mononegaviral virus vectors
Publication Date: 2011.05.31 INTERVET INT BV
  • US7951587B2 patent drawing
  • US7951587B2 patent drawing
  • US7951587B2 patent drawing

AI summary

The invention relates to a recombinant Mononegavirales virus (MV) vector comprising a foreign gene that is flanked by non-coding regions of a MV virus gene.